vs
康美（CNMD）与大都会人寿（MET）财务数据对比。点击上方公司名可切换其他公司
大都会人寿的季度营收约是康美的1.6倍（$600.0M vs $373.2M），大都会人寿同比增速更快（7.9% vs 7.9%），过去两年康美的营收复合增速更高（9.3% vs 2.0%）
康美公司是一家上市的美国医疗设备制造商，主营骨科、腹腔镜、普通外科相关医疗器械以及各类患者护理产品，总部现位于佛罗里达州拉戈，2022年7月前设于纽约州尤蒂卡。该品牌秉持以人为本的文化，以助力医疗合作方及其服务的患者为核心使命，在美国和墨西哥都设有生产基地。
大都会人寿（MetLife）是全球规模领先的保险、年金及员工福利服务提供商之一，创立于1868年，业务覆盖超60个国家和地区，服务约9000万客户，2018年位列《财富》美国500强营收排行榜第43位。
CNMD vs MET — 直观对比
营收规模更大
MET
是对方的1.6倍
$373.2M
营收增速更快
MET
高出0.0%
7.9%
两年增速更快
CNMD
近两年复合增速
2.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $373.2M | $600.0M |
| 净利润 | — | $809.0M |
| 毛利率 | 58.5% | — |
| 营业利润率 | 9.8% | — |
| 净利率 | — | 134.8% |
| 营收同比 | 7.9% | 7.9% |
| 净利润同比 | — | -36.3% |
| 每股收益（稀释后） | $0.54 | $1.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CNMDMET
| Q4 25 | $373.2M | $600.0M | ||
| Q3 25 | $337.9M | $621.0M | ||
| Q2 25 | $342.3M | $604.0M | ||
| Q1 25 | $321.3M | $611.0M | ||
| Q4 24 | $345.9M | $556.0M | ||
| Q3 24 | $316.7M | $554.0M | ||
| Q2 24 | $332.1M | $558.0M | ||
| Q1 24 | $312.3M | $577.0M |
净利润CNMDMET
| Q4 25 | — | $809.0M | ||
| Q3 25 | $2.9M | $896.0M | ||
| Q2 25 | $21.4M | $729.0M | ||
| Q1 25 | $6.0M | $945.0M | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | $49.0M | $1.3B | ||
| Q2 24 | $30.0M | $946.0M | ||
| Q1 24 | $19.7M | $867.0M |
毛利率CNMDMET
| Q4 25 | 58.5% | — | ||
| Q3 25 | 49.2% | — | ||
| Q2 25 | 55.0% | — | ||
| Q1 25 | 55.3% | — | ||
| Q4 24 | 57.3% | — | ||
| Q3 24 | 56.5% | — | ||
| Q2 24 | 55.3% | — | ||
| Q1 24 | 55.1% | — |
营业利润率CNMDMET
| Q4 25 | 9.8% | — | ||
| Q3 25 | 3.5% | — | ||
| Q2 25 | 11.1% | — | ||
| Q1 25 | 5.0% | — | ||
| Q4 24 | 15.2% | — | ||
| Q3 24 | 20.7% | — | ||
| Q2 24 | 14.2% | — | ||
| Q1 24 | 11.2% | — |
净利率CNMDMET
| Q4 25 | — | 134.8% | ||
| Q3 25 | 0.8% | 144.3% | ||
| Q2 25 | 6.3% | 120.7% | ||
| Q1 25 | 1.9% | 154.7% | ||
| Q4 24 | — | 228.6% | ||
| Q3 24 | 15.5% | 242.2% | ||
| Q2 24 | 9.0% | 169.5% | ||
| Q1 24 | 6.3% | 150.3% |
每股收益（稀释后）CNMDMET
| Q4 25 | $0.54 | $1.18 | ||
| Q3 25 | $0.09 | $1.22 | ||
| Q2 25 | $0.69 | $1.03 | ||
| Q1 25 | $0.19 | $1.28 | ||
| Q4 24 | $1.09 | $1.75 | ||
| Q3 24 | $1.57 | $1.81 | ||
| Q2 24 | $0.96 | $1.28 | ||
| Q1 24 | $0.63 | $1.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $25.6B |
| 总债务越低越好 | $834.2M | — |
| 股东权益账面价值 | $1.0B | $28.4B |
| 总资产 | $2.3B | $745.2B |
| 负债/权益比越低杠杆越低 | 0.81× | — |
8季度趋势，按日历期对齐
现金及短期投资CNMDMET
| Q4 25 | — | $25.6B | ||
| Q3 25 | — | $26.2B | ||
| Q2 25 | — | $27.5B | ||
| Q1 25 | — | $26.9B | ||
| Q4 24 | — | $25.2B | ||
| Q3 24 | — | $26.4B | ||
| Q2 24 | — | $24.6B | ||
| Q1 24 | — | $24.7B |
总债务CNMDMET
| Q4 25 | $834.2M | — | ||
| Q3 25 | $853.0M | — | ||
| Q2 25 | $881.1M | — | ||
| Q1 25 | $891.4M | — | ||
| Q4 24 | $905.1M | — | ||
| Q3 24 | $940.1M | — | ||
| Q2 24 | $965.2M | — | ||
| Q1 24 | $990.1M | — |
股东权益CNMDMET
| Q4 25 | $1.0B | $28.4B | ||
| Q3 25 | $1.0B | $28.9B | ||
| Q2 25 | $1.0B | $27.7B | ||
| Q1 25 | $977.6M | $27.5B | ||
| Q4 24 | $962.7M | $27.4B | ||
| Q3 24 | $932.9M | $30.9B | ||
| Q2 24 | $881.8M | $27.3B | ||
| Q1 24 | $854.7M | $28.5B |
总资产CNMDMET
| Q4 25 | $2.3B | $745.2B | ||
| Q3 25 | $2.3B | $719.7B | ||
| Q2 25 | $2.3B | $702.5B | ||
| Q1 25 | $2.3B | $688.3B | ||
| Q4 24 | $2.3B | $677.5B | ||
| Q3 24 | $2.3B | $705.0B | ||
| Q2 24 | $2.3B | $675.7B | ||
| Q1 24 | $2.3B | $677.6B |
负债/权益比CNMDMET
| Q4 25 | 0.81× | — | ||
| Q3 25 | 0.85× | — | ||
| Q2 25 | 0.88× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 1.09× | — | ||
| Q1 24 | 1.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $46.3M | $7.1B |
| 自由现金流经营现金流 - 资本支出 | $41.2M | — |
| 自由现金流率自由现金流/营收 | 11.0% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | — | 8.75× |
| 过去12个月自由现金流最近4个季度 | $150.9M | — |
8季度趋势，按日历期对齐
经营现金流CNMDMET
| Q4 25 | $46.3M | $7.1B | ||
| Q3 25 | $53.7M | $3.6B | ||
| Q2 25 | $29.1M | $2.2B | ||
| Q1 25 | $41.5M | $4.3B | ||
| Q4 24 | $43.3M | $4.6B | ||
| Q3 24 | $51.2M | $4.2B | ||
| Q2 24 | $43.3M | $3.5B | ||
| Q1 24 | $29.1M | $2.3B |
自由现金流CNMDMET
| Q4 25 | $41.2M | — | ||
| Q3 25 | $48.5M | — | ||
| Q2 25 | $23.4M | — | ||
| Q1 25 | $37.8M | — | ||
| Q4 24 | $39.3M | — | ||
| Q3 24 | $47.8M | — | ||
| Q2 24 | $39.7M | — | ||
| Q1 24 | $27.1M | — |
自由现金流率CNMDMET
| Q4 25 | 11.0% | — | ||
| Q3 25 | 14.4% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | 11.8% | — | ||
| Q4 24 | 11.4% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 12.0% | — | ||
| Q1 24 | 8.7% | — |
资本支出强度CNMDMET
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | 1.1% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 0.7% | — |
现金转化率CNMDMET
| Q4 25 | — | 8.75× | ||
| Q3 25 | 18.78× | 3.98× | ||
| Q2 25 | 1.36× | 3.00× | ||
| Q1 25 | 6.88× | 4.51× | ||
| Q4 24 | — | 3.63× | ||
| Q3 24 | 1.05× | 3.11× | ||
| Q2 24 | 1.44× | 3.69× | ||
| Q1 24 | 1.48× | 2.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNMD
| Transferred At Point In Time | $358.5M | 96% |
| Transferred Over Time | $14.7M | 4% |
MET
| Other | $165.0M | 28% |
| Prepaidlegalplansandadministrativeonlycontracts | $158.0M | 26% |
| Vision Fee For Service Arrangements | $140.0M | 23% |
| Administrative Service | $76.0M | 13% |
| Distribution Service | $36.0M | 6% |
| Feebasedinvestmentmanagementservices | $25.0M | 4% |
